Detalles de la búsqueda
1.
First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.
Oncology
; 90(2): 88-96, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26784946
2.
Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.
BMC Cancer
; 16: 318, 2016 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27194176
3.
Single-port or Classic Laparoscopy Compared With Laparotomy to Assess the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer.
J Minim Invasive Gynecol
; 23(5): 825-32, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27068278
4.
Managing Endometrial Cancer: The Role of Pelvic Lymphadenectomy and Secondary Surgery.
Ann Surg Oncol
; 22 Suppl 3: S936-43, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26305024
5.
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial.
BMC Cancer
; 15: 127, 2015 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25884155
6.
Minimally invasive surgical management of early-stage cervical cancer: an analysis of the risk factors of surgical complications and of oncologic outcomes.
Int J Gynecol Cancer
; 25(4): 714-21, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25647258
7.
Safety of adjuvant intensity-modulated postoperative radiation therapy in endometrial cancer: Clinical data and dosimetric parameters according to the International Commission on Radiation Units (ICRU) 83 report.
Rep Pract Oncol Radiother
; 20(5): 385-92, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26549997
8.
Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome.
BMC Cancer
; 13: 413, 2013 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24010566
9.
A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial.
Eur Urol Open Sci
; 54: 80-87, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545850
10.
Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study.
Cancers (Basel)
; 15(4)2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831483
11.
Correlation between toxicity and dosimetric parameters for adjuvant intensity modulated radiation therapy of breast cancer: a prospective study.
Sci Rep
; 11(1): 3626, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33574446
12.
[Evaluation of drug interactions in patients treated for a lung or digestive cancer]. / Évaluation des interactions médicamenteuses chez des patients traités pour un cancer pulmonaire ou digestif.
Bull Cancer
; 107(11): 1108-1117, 2020 Nov.
Artículo
en Francés
| MEDLINE | ID: mdl-33012503
13.
A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO Trial.
Int J Radiat Oncol Biol Phys
; 106(1): 116-123, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31604131
14.
Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series.
Sci Rep
; 10(1): 11201, 2020 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641798
15.
Prospective Study of Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer.
Cancers (Basel)
; 12(12)2020 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33419316
16.
GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol.
BMJ Open
; 9(8): e026666, 2019 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31377694
17.
Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life.
Sci Rep
; 9(1): 2759, 2019 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30808911
18.
Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer.
Sci Rep
; 8(1): 10407, 2018 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29991748
19.
Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO).
PLoS One
; 12(11): e0187794, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29190707
20.
Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
Eur J Cancer
; 87: 189-198, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29103666